KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares Outstanding
Ratios

Astrana Health (ASTH) Long-Term Debt Repayments (2016 - 2025)

Astrana Health (ASTH) has disclosed Long-Term Debt Repayments for 12 consecutive years, with $147000.0 as the latest value for Q1 2025.

  • Quarterly Long-Term Debt Repayments fell 17.88% to $147000.0 in Q1 2025 from the year-ago period, while the trailing twelve-month figure was $18.5 million through Mar 2025, down 90.98% year-over-year, with the annual reading at $495.3 million for FY2025, 2577.24% up from the prior year.
  • Long-Term Debt Repayments hit $147000.0 in Q1 2025 for Astrana Health, down from $18.0 million in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $235.8 million in Q2 2021 to a low of -$238.0 million in Q4 2021.
  • Historically, Long-Term Debt Repayments has averaged $13.2 million across 5 years, with a median of $154000.0 in 2023.
  • Biggest five-year swings in Long-Term Debt Repayments: soared 141688.89% in 2023 and later tumbled 88944.55% in 2024.
  • Year by year, Long-Term Debt Repayments stood at -$238.0 million in 2021, then skyrocketed by 100.06% to $144000.0 in 2022, then skyrocketed by 141688.89% to $204.2 million in 2023, then crashed by 91.2% to $18.0 million in 2024, then tumbled by 99.18% to $147000.0 in 2025.
  • Business Quant data shows Long-Term Debt Repayments for ASTH at $147000.0 in Q1 2025, $18.0 million in Q4 2024, and -$179.5 million in Q3 2024.